Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of July, 2022

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches. In respect of the first tranche, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the first tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on May 27, 2021, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended July 31, 2022, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:



   Ordinary Shares
     Volume Weighted
Average Price Paid
per Ordinary Share
     Highest Price Paid      Lowest Price Paid  

July 1, 2022

     139,180        173.82p        177.60p        170.80p  

July 4, 2022

     32,319        179.24p        179.40p        176.00p  

July 5, 2022

     146,105        176.64p        180.00p        173.00p  

July 6, 2022

     146,990        179.64p        180.60p        178.60p  

July 7, 2022

     97,574        182.44p        183.60p        180.80p  

July 8, 2022

     71,762        184.99p        185.20p        182.80p  

July 11, 2022

     113,063        188.22p        188.60p        185.40p  

July 12, 2022

     125,832        189.17p        191.20p        184.00p  

July 13, 2022

     145,749        184.46p        194.40p        178.40p  

July 14, 2022

     124,561        186.01p        188.20p        181.60p  

July 15, 2022

     140,304        187.69p        189.00p        183.80p  

July 18, 2022

     94,129        186.69p        191.60p        181.80p  

July 19, 2022

     90,786        186.67p        191.20p        182.20p  

July 20, 2022

     60,212        193.94p        194.00p        193.00p  

July 21, 2022

     24,830        196.55p        196.60p        195.40p  

July 22, 2022

     86,484        196.69p        199.20p        193.20p  

July 25, 2022

     80,693        194.39p        198.00p        190.80p  

July 26, 2022

     74,107        196.13p        198.00p        190.60p  

July 27, 2022

     74,961        196.42p        198.80p        192.60p  

July 28, 2022

     68,096        197.26p        203.00p        195.00p  

July 29, 2022

     68,851        198.30p        201.50p        194.80p  

During the month ended July 31, 2022, the Company repurchased an aggregate of 2,006,588 Ordinary Shares. As of July 31, 2022, the Company’s issued share capital was 288,689,450 shares, 4,016,857 of which were held in treasury, resulting in total voting rights in the Company of 284,672,593 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

July 1, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4426432.html

July 4, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4428099.html

July 5, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4429594.html

July 6, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4431262.html

July 7, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4432843.html

July 8, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4434455.html

July 11, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4436183.html

July 12, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4437753.html

July 13, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4439297.html

July 14, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4440931.html

July 15, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4442387.html

July 18, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4444038.html

July 19, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4445759.html

July 20, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4447410.html

July 21, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4448975.html

July 22, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4450474.html

July 25, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4452129.html

July 26, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4453651.html

July 27, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4455300.html

July 28, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4456985.html

July 29, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4458711.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: August 4, 2022   By:   /s/ Daphne Zohar
    Name:   Daphne Zohar
    Title:   Chief Executive Officer